Literature DB >> 16183702

Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.

João Paulo Capela1, Andreas Meisel, Artur Reis Abreu, Paula Sério Branco, Luísa Maria Ferreira, Ana Maria Lobo, Fernando Remião, Maria Lurdes Bastos, Félix Carvalho.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") is a widely abused, psychoactive recreational drug. There is growing evidence that the MDMA neurotoxic profile may be highly dependent on both its hepatic metabolism and body temperature. Metabolism of MDMA involves N-demethylation to 3,4-methylenedioxyamphetamine (MDA), which is also a drug of abuse. MDMA and MDA are O-demethylenated to N-methyl-alpha-methyldopamine (N-Me-alpha-MeDA) and alpha-methyldopamine (alpha-MeDA), respectively, both of which are catechols that can undergo oxidation to the corresponding ortho-quinones. In the presence of glutathione (GSH), ortho-quinones may be conjugated with GSH to form glutathionyl adducts. In this study, we evaluated the neurotoxicity of MDMA and three of its metabolites obtained by synthesis, N-Me-alpha-MeDA, alpha-MeDA, and 5-(GSH)-alpha-MeDA [5-(glutathion-S-yl)-alpha-methyldopamine] in rat cortical neuronal serum-free cultures under normal (36.5 degrees C) and hyperthermic (40 degrees C) conditions. Cell viability was assessed, and the mechanism of cell death was also evaluated. Our study shows that these metabolites are more neurotoxic [5-(GSH)-alpha-MeDA being the most toxic] than the parent compound MDMA. The neurotoxicity of MDMA metabolites was partially prevented by the antioxidants N-acetylcystein and also, in a minor extent, by alpha-phenyl-N-tert-butyl nitrone. All the tested compounds induced apoptotic cell death in cortical neurons, and their neurotoxic effect was potentiated under hyperthermic conditions. These data suggest that MDMA metabolites, especially under hyperthermic conditions, contribute to MDMA-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183702     DOI: 10.1124/jpet.105.092577

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

Review 1.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

3.  Lysosome-associated membrane protein 1 is a major SSEA-1-carrier protein in mouse neural stem cells.

Authors:  Hirokazu Yagi; Makoto Yanagisawa; Koichi Kato; Robert K Yu
Journal:  Glycobiology       Date:  2010-03-31       Impact factor: 4.313

Review 4.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

5.  Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes.

Authors:  Daniel José Barbosa; João Paulo Capela; Jorge Ma Oliveira; Renata Silva; Luísa Maria Ferreira; Filipa Siopa; Paula Sério Branco; Eduarda Fernandes; José Alberto Duarte; Maria de Lourdes Bastos; Félix Carvalho
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study.

Authors:  Fatemeh Kermanian; Mehdi Mehdizadeh; Mansureh Soleimani; Ali Reza Ebrahimzadeh Bideskan; Majid Asadi-Shekaari; Hamed Kheradmand; Hossein Haghir
Journal:  Metab Brain Dis       Date:  2012-09-09       Impact factor: 3.584

Review 7.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

8.  3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

Authors:  Jack W Lipton; Emeline G Tolod; Valerie B Thompson; Lin Pei; Katrina L Paumier; Brian T Terpstra; Kaari A Lynch; Timothy J Collier; Caryl E Sortwell
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

9.  MDMA (Ecstasy) decreases the number of neurons and stem cells in embryonic cortical cultures.

Authors:  Anna M S Kindlundh-Högberg; Chris Pickering; Grzegorz Wicher; David Hobér; Helgi B Schiöth; Asa Fex Svenningsen
Journal:  Cell Mol Neurobiol       Date:  2009-06-19       Impact factor: 5.046

10.  Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse.

Authors:  Raúl López-Arnau; José Martínez-Clemente; Sonia Abad; David Pubill; Jorge Camarasa; Elena Escubedo
Journal:  Psychopharmacology (Berl)       Date:  2014-04-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.